Last10K.com

Akorn Inc (AKRX) SEC Filing 8-K Material Event for the period ending Monday, April 27, 2020

Akorn Inc

CIK: 3116 Ticker: AKRX

View differences made from one to another to evaluate Akorn Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Akorn Inc.

Continue

Assess how Akorn Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Akorn Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: AKRX
CIK: 3116
Form Type: 8-K Corporate News
Accession Number: 0001104659-20-055674
Submitted to the SEC: Fri May 01 2020 5:26:15 PM EST
Accepted by the SEC: Fri May 01 2020
Period: Monday, April 27, 2020
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/akrx/0001104659-20-055674.htm